Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates
Follow the latest updates of the outbreak聽on our聽timeline.
and join the list of biotech companies that have announced plans to develop a vaccine for China鈥檚 new, deadly coronavirus.
The first case of the coronavirus infection in the US was confirmed on 21 January.
Vir is leveraging various platforms to evaluate if its previously identified monoclonal antibodies (mAbs) against coronavirus can bind and neutralise the virus.
chief scientific officer Herbert Virgin said: 鈥淲e have a library of multiple fully-human mAbs that bind and neutralise coronaviruses such as SARS and MERS. These mAbs were discovered using our antibody platform that identifies mAbs from survivors of an infection.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData鈥淪ome of these mAbs are able to neutralise zoonotic coronaviruses and we believe may have the potential to treat and prevent Wuhan coronavirus. We are also exploring the isolation of new mAbs specific for this virus.鈥�
To find additional approaches to contain the outbreak, scientists at Vir also intend to use whole genome CRISPR-based screening to detect the host receptor responsible for the infection.
, which previously developed a vaccine against the Middle East respiratory syndrome (MERS) virus, also said it is working on a vaccine candidate for the Wuhan coronavirus. 聽The company intends to use recombinant nanoparticle technology to develop the vaccine.
These announcements come after the US National Institutes of Health (NIH) confirmed that works are underway to develop a coronavirus vaccine. Biotechnology company Moderna is collaborating with NIH and its units to develop a vaccine.
